The draft guidance document can be found here. April 8, 2022 RE: Development of Non-Opioid Analgesics for Acute Pain: Guidance for Industry; Draft Date February
Lotus Clinical Research has worked with Concentric for several years and through multiple studies on their novel non-opioid analgesic vocacapsaicin. Recently, Lotus CRO has been
We are a specialty analgesic CRO and site that supports all phases of
discovery for novel analgesics. We provide scientific leadership and
have extensive experience with the analgesic approval process.